Corindus Vascular Robotics, Inc., a developer of precision vascular robotics, featured its CorPath GRX System at the recent Transcatheter Cardiovascular Therapeutics (TCT) 2018 Conference in California, USA.
Corindus’ CorPath GRX is the first FDA-cleared medical device for robotic-assisted vascular interventions.
“There has been tremendous progress made in the development of our robotic platform, including procedural automation and remote technology, which we believe will have the power to change the treatment paradigm and increase patient access to care,” said J. Aaron Grantham, M.D., Cardiovascular Chief Medical Officer of Corindus.
[Read more…] about Corindus shows CorPath GRX System at cardiovascular conference